Vanessa Ajemian Barss, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 10 | 1989 | 1236 | 0.330 |
Why?
|
| Fetal Diseases | 7 | 1989 | 903 | 0.220 |
Why?
|
| Erythroblastosis, Fetal | 4 | 1988 | 60 | 0.190 |
Why?
|
| Ultrasonography | 13 | 1989 | 5985 | 0.180 |
Why?
|
| Pregnancy in Diabetics | 3 | 1989 | 179 | 0.170 |
Why?
|
| Blood Transfusion, Intrauterine | 3 | 1988 | 26 | 0.160 |
Why?
|
| Fetal Heart | 2 | 1987 | 276 | 0.120 |
Why?
|
| Fetal Monitoring | 3 | 1989 | 70 | 0.100 |
Why?
|
| Edema | 2 | 1986 | 789 | 0.100 |
Why?
|
| Rh Isoimmunization | 2 | 1988 | 21 | 0.100 |
Why?
|
| Pregnancy, Animal | 2 | 1988 | 134 | 0.090 |
Why?
|
| Prazosin | 1 | 1988 | 96 | 0.080 |
Why?
|
| Pregnancy, Multiple | 2 | 1986 | 217 | 0.080 |
Why?
|
| Indomethacin | 1 | 1988 | 332 | 0.070 |
Why?
|
| Uterine Contraction | 1 | 1988 | 93 | 0.070 |
Why?
|
| Maternal Age | 2 | 1989 | 802 | 0.070 |
Why?
|
| Pregnancy | 26 | 1995 | 29144 | 0.070 |
Why?
|
| Amniotic Fluid | 2 | 1988 | 370 | 0.070 |
Why?
|
| Chorion | 1 | 1985 | 117 | 0.070 |
Why?
|
| Digestive System Abnormalities | 1 | 1985 | 52 | 0.060 |
Why?
|
| Norepinephrine | 1 | 1988 | 909 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 1985 | 309 | 0.060 |
Why?
|
| Cardiac Output | 1 | 1987 | 854 | 0.060 |
Why?
|
| Amnion | 1 | 1985 | 209 | 0.060 |
Why?
|
| Needles | 1 | 1986 | 449 | 0.060 |
Why?
|
| Fetal Death | 1 | 1985 | 448 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 1986 | 608 | 0.050 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1985 | 500 | 0.050 |
Why?
|
| Antibodies | 1 | 1988 | 2460 | 0.040 |
Why?
|
| Hydrops Fetalis | 2 | 1989 | 107 | 0.040 |
Why?
|
| Heparin | 1 | 1985 | 1637 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 1985 | 1151 | 0.040 |
Why?
|
| Gestational Age | 7 | 1989 | 3493 | 0.040 |
Why?
|
| Fetal Blood | 3 | 1988 | 1318 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 1986 | 1848 | 0.040 |
Why?
|
| Delivery, Obstetric | 3 | 1995 | 906 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 1989 | 140 | 0.030 |
Why?
|
| Blood Specimen Collection | 2 | 1988 | 246 | 0.030 |
Why?
|
| Labor, Induced | 2 | 1995 | 146 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1985 | 2376 | 0.030 |
Why?
|
| Pessaries | 1 | 1992 | 17 | 0.030 |
Why?
|
| Fetal Organ Maturity | 2 | 1989 | 82 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1995 | 333 | 0.030 |
Why?
|
| Amniocentesis | 2 | 1988 | 116 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1985 | 2861 | 0.020 |
Why?
|
| Fetal Growth Retardation | 2 | 1985 | 570 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 5751 | 0.020 |
Why?
|
| Female | 27 | 1995 | 380194 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1992 | 600 | 0.020 |
Why?
|
| Cesarean Section | 2 | 1995 | 1365 | 0.020 |
Why?
|
| Prostaglandins F | 1 | 1988 | 81 | 0.020 |
Why?
|
| Infant, Newborn | 8 | 1995 | 25625 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1988 | 107 | 0.020 |
Why?
|
| Dinoprost | 1 | 1988 | 138 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 3 | 1985 | 732 | 0.020 |
Why?
|
| Fetal Distress | 1 | 1987 | 40 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 636 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 149 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 1989 | 1150 | 0.020 |
Why?
|
| Triplets | 1 | 1985 | 43 | 0.020 |
Why?
|
| Kell Blood-Group System | 1 | 1985 | 22 | 0.020 |
Why?
|
| Myometrium | 1 | 1987 | 181 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1988 | 571 | 0.020 |
Why?
|
| Pregnancy, Prolonged | 1 | 1985 | 9 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 419 | 0.020 |
Why?
|
| Prune Belly Syndrome | 1 | 1984 | 5 | 0.020 |
Why?
|
| Fetofetal Transfusion | 1 | 1985 | 104 | 0.020 |
Why?
|
| Polyploidy | 1 | 1984 | 114 | 0.020 |
Why?
|
| Rabbits | 2 | 1988 | 4894 | 0.020 |
Why?
|
| Twins | 1 | 1985 | 339 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1986 | 449 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1984 | 130 | 0.010 |
Why?
|
| Humans | 25 | 1995 | 744343 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1988 | 1681 | 0.010 |
Why?
|
| Placenta Previa | 1 | 1984 | 117 | 0.010 |
Why?
|
| Pregnancy Outcome | 2 | 1989 | 2795 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1988 | 1813 | 0.010 |
Why?
|
| Fetus | 1 | 1989 | 1880 | 0.010 |
Why?
|
| Counseling | 1 | 1989 | 1523 | 0.010 |
Why?
|
| Parity | 2 | 1995 | 929 | 0.010 |
Why?
|
| Adult | 9 | 1995 | 214055 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1989 | 2044 | 0.010 |
Why?
|
| Dopamine | 1 | 1987 | 1591 | 0.010 |
Why?
|
| Risk | 3 | 1987 | 9687 | 0.010 |
Why?
|
| Obstetric Labor Complications | 2 | 1995 | 238 | 0.010 |
Why?
|
| Face | 1 | 1984 | 994 | 0.010 |
Why?
|
| Exercise Test | 1 | 1985 | 2074 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 1416 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1985 | 880 | 0.010 |
Why?
|
| Placenta | 1 | 1985 | 1698 | 0.010 |
Why?
|
| Uterine Inertia | 1 | 1995 | 29 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1989 | 3336 | 0.010 |
Why?
|
| Midwifery | 1 | 1995 | 132 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1985 | 3461 | 0.010 |
Why?
|
| Infant Mortality | 2 | 1989 | 754 | 0.010 |
Why?
|
| Oxytocin | 1 | 1995 | 394 | 0.010 |
Why?
|
| Macrophages | 1 | 1985 | 5655 | 0.010 |
Why?
|
| Time Factors | 2 | 1995 | 40075 | 0.010 |
Why?
|
| Polyhydramnios | 1 | 1989 | 41 | 0.010 |
Why?
|
| Kidney | 1 | 1984 | 7186 | 0.010 |
Why?
|
| Fetal Macrosomia | 1 | 1989 | 124 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1992 | 968 | 0.000 |
Why?
|
| Chorioamnionitis | 1 | 1989 | 155 | 0.000 |
Why?
|
| Obstetric Labor, Premature | 1 | 1989 | 279 | 0.000 |
Why?
|
| Dihydroergotoxine | 1 | 1987 | 21 | 0.000 |
Why?
|
| Phentolamine | 1 | 1987 | 104 | 0.000 |
Why?
|
| Apomorphine | 1 | 1987 | 150 | 0.000 |
Why?
|
| Karyotyping | 1 | 1988 | 1243 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1986 | 56 | 0.000 |
Why?
|
| Punctures | 1 | 1988 | 374 | 0.000 |
Why?
|
| Pleural Effusion | 1 | 1989 | 338 | 0.000 |
Why?
|
| Lung | 1 | 1984 | 9856 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1988 | 514 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1987 | 1157 | 0.000 |
Why?
|
| Apgar Score | 1 | 1984 | 123 | 0.000 |
Why?
|
| Congenital Abnormalities | 1 | 1988 | 707 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1985 | 981 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1985 | 53288 | 0.000 |
Why?
|
| Neck | 1 | 1985 | 697 | 0.000 |
Why?
|
| Pre-Eclampsia | 1 | 1989 | 1200 | 0.000 |
Why?
|
| Anemia | 1 | 1989 | 1506 | 0.000 |
Why?
|
| Head | 1 | 1985 | 880 | 0.000 |
Why?
|
| Animals | 2 | 1988 | 168757 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12026 | 0.000 |
Why?
|
| Adolescent | 1 | 1985 | 85781 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1987 | 3748 | 0.000 |
Why?
|
| Birth Weight | 1 | 1984 | 2069 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1989 | 15076 | 0.000 |
Why?
|
| Skin | 1 | 1985 | 4364 | 0.000 |
Why?
|
| Male | 2 | 1986 | 350118 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1988 | 39050 | 0.000 |
Why?
|
| Risk Factors | 1 | 1989 | 72290 | 0.000 |
Why?
|